140 related articles for article (PubMed ID: 31426742)
1. In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants.
Rodríguez-Ruiz HA; Garibay-Cerdenares OL; Illades-Aguiar B; Montaño S; Jiang X; Leyva-Vázquez MA
BMC Mol Cell Biol; 2019 Aug; 20(1):35. PubMed ID: 31426742
[TBL] [Abstract][Full Text] [Related]
2. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
Hadami K; Saby C; Dakka N; Collin G; Attaleb M; Khyatti M; Filali-Maltouf A; Morjani H; El Mzibri M
Gene; 2021 Jul; 791():145709. PubMed ID: 33984442
[TBL] [Abstract][Full Text] [Related]
3. Changes in global gene expression profiles induced by HPV 16 E6 oncoprotein variants in cervical carcinoma C33-A cells.
Zacapala-Gómez AE; Del Moral-Hernández O; Villegas-Sepúlveda N; Hidalgo-Miranda A; Romero-Córdoba SL; Beltrán-Anaya FO; Leyva-Vázquez MA; Alarcón-Romero Ldel C; Illades-Aguiar B
Virology; 2016 Jan; 488():187-95. PubMed ID: 26655236
[TBL] [Abstract][Full Text] [Related]
4. Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells.
Garibay-Cerdenares OL; Sánchez-Meza LV; Encarnación-Guevara S; Hernández-Ortíz M; Martínez-Batallar G; Torres-Rojas FI; Mendoza-Catalán MÁ; Moral-Hernández OD; Leyva-Vázquez MA; Illades-Aguiar B
Cancer Genomics Proteomics; 2021; 18(3):273-283. PubMed ID: 33893080
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
[TBL] [Abstract][Full Text] [Related]
7. [The study of gene variation and phylogenetic analysis of HPV16 E6 and E7 gene in Hubei, China].
Ding XH; Zhang F; Cai HB; Yang ZQ
Bing Du Xue Bao; 2010 Sep; 26(5):368-72. PubMed ID: 21043136
[TBL] [Abstract][Full Text] [Related]
8. Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants.
Sabol I; Matovina M; Si-Mohamed A; Grce M
PLoS One; 2012; 7(7):e41045. PubMed ID: 22911739
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel E6-E7 sequence variants of human papillomavirus 16.
Tsakogiannis D; Kyriakopoulou Z; Amoutzias G; Ruether IG; Dimitriou TG; Panotopoulou E; Markoulatos P
Arch Virol; 2013 Apr; 158(4):821-8. PubMed ID: 23208280
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers.
Choi BS; Kim SS; Yun H; Jang DH; Lee JS
J Med Virol; 2007 Apr; 79(4):426-30. PubMed ID: 17311337
[TBL] [Abstract][Full Text] [Related]
12. The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.
Zanier K; Stutz C; Kintscher S; Reinz E; Sehr P; Bulkescher J; Hoppe-Seyler K; Travé G; Hoppe-Seyler F
PLoS One; 2014; 9(11):e112514. PubMed ID: 25383876
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery.
Kolluru S; Momoh R; Lin L; Mallareddy JR; Krstenansky JL
BMC Mol Cell Biol; 2019 Aug; 20(1):30. PubMed ID: 31387520
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
[TBL] [Abstract][Full Text] [Related]
15. [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
Ren Z; Wu HW; Song J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):88-90. PubMed ID: 20104743
[TBL] [Abstract][Full Text] [Related]
16. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
17. Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China.
Yu LL; Kang LN; Zhao FH; Lei XQ; Qin Y; Wu ZN; Wang H; Chen W; Qiao YL
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1167-74. PubMed ID: 27197295
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus 16 E6, E7 genes and Long Control Region in cervical samples from Uruguayan women.
Ramas V; Mirazo S; Bonilla S; Ruchansky D; Arbiza J
Gene; 2018 May; 654():103-109. PubMed ID: 29454092
[TBL] [Abstract][Full Text] [Related]
19. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
20. Modeling and Molecular Dynamics of the 3D Structure of the HPV16 E7 Protein and Its Variants.
Bello-Rios C; Montaño S; Garibay-Cerdenares OL; Araujo-Arcos LE; Leyva-Vázquez MA; Illades-Aguiar B
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
